Induction of apoptosis in p53-deficient L1210 cells by an I-K-B-α-inhibitor (Bay 11-7085) via a NF-K-B-independent mechanism

被引:4
作者
Cory, AH [1 ]
Cory, JG [1 ]
机构
[1] E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA
来源
ADVANCES IN ENZYME REGULATION, VOL 45 | 2005年 / 45卷
关键词
D O I
10.1016/j.advenzreg.2005.02.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The effects of Bay 11-7085, an inhibitor of I-κ-B-α kinase, were compared in the wild-type and deoxyadenosine-resistant mouse leukemia cell lines. At higher concentrations, Bay 11-7085 caused apoptosis and necrosis in the two cell lines. However, at much lower concentrations of Bay 11-7085, the deoxyadenosine-resistant cells became much more apoptotic than the parental wild-type L1210 cells. Under these conditions (low drug concentrations), the level of apoptotic cells far exceeded the fraction of necrotic cells. The apoptotic effects of Bay 11-7085 on the deoxyadenosine-resistant cells was both time- and concentration-dependent. Caspase-3 activity was activated in the Bay 11-7085-treated cells. The molecular basis for the difference in the apoptotic response between the wild-type and deoxyadenosine-resistant L1210 cells is not defined at this time, but these cell lines may provide a comparative model system in which differences in the cells that lead to apoptotic or necrotic responses to drugs can be defined and used in development of appropriate drugs for clinical use. © 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:85 / 93
页数:9
相关论文
共 22 条
[1]
CARTER GL, 1989, ADV ENZYME REGUL, V29, P123, DOI 10.1016/0065-2571(89)90097-6
[2]
Inhibitors of diverse metabolic steps cause increased apoptosis in deoxyadenosine-resistant mouse leukemia L1210 cells that lack p53 expression: convergence at caspase-3 activation [J].
Cory, AH ;
Edwards, CC ;
Hall, JG ;
Cory, JG .
ADVANCES IN ENZYME REGULATION, VOL 43, 2003, 43 :29-45
[3]
Cory AH, 2002, ANTICANCER RES, V22, P3805
[4]
Cory AH, 2001, ANTICANCER RES, V21, P3807
[5]
Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agents [J].
Cory, AH ;
He, AWR ;
Cory, JG .
ADVANCES IN ENZYME REGULATION, VOL 38, 1998, 38 :3-18
[6]
Cory AH, 2000, ANTICANCER RES, V20, P4171
[7]
CORY AH, 2004, IN PRESS ADV ENZYME, V44
[8]
CORY JG, 1988, CANCER RES, V48, P839
[9]
Cory JG, 1996, ANTICANCER RES, V16, P3483
[10]
CORY JG, 1992, CANCER RES, V52, P2000